Etiology of chronic hepatitis in France: predominant role of hepatitis C virus (Q43036522)

12 November 2017

Etiology of chronic hepatitis in France: predominant role of hepatitis C virus (English)

1 reference

12 November 2017

1 reference

1

1 reference

12 November 2017

Marcellin P

2

1 reference

12 November 2017

Martinot-Peignoux M

3

1 reference

12 November 2017

Pham BN

4

1 reference

12 November 2017

Degott C

5

1 reference

12 November 2017

Level R

6

1 reference

12 November 2017

Lefort V

7

1 reference

12 November 2017

Benhallem A

8

1 reference

12 November 2017

Erlinger S

9

1 reference

12 November 2017

Benhamou JP

10

1 reference

12 November 2017

1 October 1994

1 reference

12 November 2017

Journal of Hepatology

1 reference

12 November 2017

21

1 reference

12 November 2017

4

1 reference

12 November 2017

618-623

1 reference

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Second generation (RIBA) test in diagnosis of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Second generation tests in diagnosis of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

New kit on the block: Evaluation of second-generation assays for detection of antibody to the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Improved detection of hepatitis c virus antibodies in high-risk populations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Reactivity to c33c antigen as a marker of hepatitis C virus multiplication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Chronic non-B, non-C hepatitis among blood donors assessed with HCV third generation tests and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Criteria of drug-induced liver disorders. Report of an international consensus meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Chronic active hepatitis: the spectrum of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Frequency of antibody to hepatitis C virus in asymptomatic HBsAg-negative chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Antibody to hepatitis C virus and liver disease in volunteer blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Type 2 autoimmune hepatitis and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

Clinical backgrounds of the patients having different types of hepatitis C virus genomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980110-X

7 January 2021

10.1016/S0168-8278(94)80110-X

Identifiers

DOI

1 reference

12 November 2017

1 reference